Diagnostic Medical Systems S.A. (FRA:DMS1)

FRA:DMS1 Statistics

Total Valuation

FRA:DMS1 has a market cap or net worth of EUR 33.67 million. The enterprise value is 51.46 million.

Market Cap	33.67M
Enterprise Value	51.46M

Important Dates

The next estimated earnings date is Tuesday, April 14, 2026.

Earnings Date	Apr 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	25.90M
Shares Outstanding	n/a
Shares Change (YoY)	+29.76%
Shares Change (QoQ)	-15.82%
Owned by Insiders (%)	3.47%
Owned by Institutions (%)	n/a
Float	12.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.68
PB Ratio	2.41
P/TBV Ratio	8.55
P/FCF Ratio	n/a
P/OCF Ratio	13.44
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.25, with an EV/FCF ratio of -90.27.

EV / Earnings	-30.87
EV / Sales	1.04
EV / EBITDA	18.25
EV / EBIT	77.38
EV / FCF	-90.27

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 1.39.

Current Ratio	1.16
Quick Ratio	0.56
Debt / Equity	1.39
Debt / EBITDA	6.86
Debt / FCF	-33.94
Interest Coverage	0.80

Financial Efficiency

Return on equity (ROE) is -11.62% and return on invested capital (ROIC) is 1.30%.

Return on Equity (ROE)	-11.62%
Return on Assets (ROA)	0.78%
Return on Invested Capital (ROIC)	1.30%
Return on Capital Employed (ROCE)	2.32%
Revenue Per Employee	353,386
Profits Per Employee	-11,907
Employee Count	129
Asset Turnover	0.93
Inventory Turnover	2.01

Taxes

In the past 12 months, FRA:DMS1 has paid 194,000 in taxes.

Income Tax	194,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +80.85% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+80.85%
50-Day Moving Average	1.25
200-Day Moving Average	1.13
Relative Strength Index (RSI)	47.80
Average Volume (20 Days)	58

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:DMS1 had revenue of EUR 49.47 million and -1.67 million in losses. Loss per share was -0.07.

Revenue	49.47M
Gross Profit	18.76M
Operating Income	665,000
Pretax Income	-1.34M
Net Income	-1.67M
EBITDA	2.25M
EBIT	665,000
Loss Per Share	-0.07

Balance Sheet

The company has 2.99 million in cash and 19.35 million in debt, giving a net cash position of -16.36 million.

Cash & Cash Equivalents	2.99M
Total Debt	19.35M
Net Cash	-16.36M
Net Cash Per Share	n/a
Equity (Book Value)	13.95M
Book Value Per Share	0.60
Working Capital	4.70M

Cash Flow

In the last 12 months, operating cash flow was 2.51 million and capital expenditures -3.08 million, giving a free cash flow of -570,000.

Operating Cash Flow	2.51M
Capital Expenditures	-3.08M
Free Cash Flow	-570,000
FCF Per Share	n/a

Margins

Gross margin is 37.92%, with operating and profit margins of 1.34% and -3.37%.

Gross Margin	37.92%
Operating Margin	1.34%
Pretax Margin	-2.70%
Profit Margin	-3.37%
EBITDA Margin	4.55%
EBIT Margin	1.34%
FCF Margin	n/a

Dividends & Yields

FRA:DMS1 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.76%
Shareholder Yield	-29.76%
Earnings Yield	-4.95%
FCF Yield	-1.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:DMS1 has an Altman Z-Score of 1.24 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.24
Piotroski F-Score	4